The move comes after a recent investigation revealed that patients in some parts of the country are missing out on glucose monitoring devices.
Abbott’s Freestyle Libre is the only glucose monitoring system available in the UK. The wearable device sends glucose levels to a smartphone or e-reader, and eliminates the need for finger prick testing.
At present, only 3-5% of type 1 diabetes patients in England have access to Freestyle Libre, even though 20-25% of patients are eligible.